ASKA Pharmaceutical Holdings Co.,Ltd.

4886.T
Drug Manufacturers - Specialty & Generic
2026/01/16 Updated
Market Cap: $385.4M (¥61.1B)
Stock Price: $13.57 (¥2,151)
Exchange Rate: 1 USD = ¥158.48

Stock Price Chart

2026/01/16 Updated
12.80
PER (Price Earnings Ratio)
vs Industry Avg: +3.3
0.91
PBR (Price to Book Ratio)
vs Industry Avg: -0.4
2.60%
Dividend Yield
vs Industry Avg: -0.35%

Price Trend

2026/01/16 Updated
Short-term
5-Day MA
+1.31%
Near-term
25-Day MA
+5.50%
Mid-term
75-Day MA
+2.98%
Long-term
200-Day MA
-4.28%

Price & Trading Details

2026/01/16 Updated

PRICE

Previous Close ¥2,133
Open ¥2,140
High ¥2,160
Low ¥2,135
Close ¥2,151

TRADING

Volume 64,100
Average Volume 57,569
Turnover ¥1億
Min. Purchase ¥215,100

Dividend History 4Years Growth

Updated 2026/01/11
-%
Dividend Yield
¥57
Annual Dividend
+26.7%
YoY Growth
31.7%
Payout Ratio
Year Dividend Change
2025 ¥57 +26.7%
2024 ¥45 +60.7%
2023 ¥28 +75.0%
2022 ¥16 +128.6%
2021 ¥7 -

Financial Performance

2026/01/11 Updated

No financial data available

Latest IR Information

  • No IR information found for this company.

    Searched stock code: 4886

Latest News (5 items)

Company Information

English Name ASKA Pharmaceutical Holdings Co.,Ltd.
Japanese Name あすか製薬ホールディングス(株)
Stock Code 4886.T (JPX)
Sector / Industry Healthcare / Drug Manufacturers - Specialty & Generic
Website https://www.aska-pharma-hd.co.jp
Employees 1,632

About

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.

Data provided by Yahoo Finance